This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
ResMed Inc.
Q22020
1/30/2020
Christine
Conference Operator
Welcome to the second fiscal year 2020 ResMed earnings conference call. My name is Christine, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session. Please note this conference is being recorded. I would now like to turn the call over to Amy Wakeham, Vice President of Investor Relations and Corporate Communications. Amy, you may begin.
Amy Wakeham
Vice President, Investor Relations and Corporate Communications
Great. Thank you, Christine. Good afternoon and good morning, everyone. Thanks for joining us and welcome to ResMed's second quarter fiscal year 2020 earnings call. This call is being webcast live and the replay along with a copy of the earnings press release and our updated investor presentation will be available on the investor relations section of our corporate website later today. Joining me on the call today to discuss our quarterly results are CEO and CFO Brett Steele. Other members...
Christine
Conference Operator
Ladies and gentlemen, this is the operator. I apologize but there will be a slight delay in today's conference. Please hold. The conference will resume momentarily. Thank you for your patience.
You're reading a preview of the RMD Q2 2020 earnings call.
Free account.
Disclaimer